title: Roundtable discussion: Part III--Hypertension management in health plans.
abstract: In the final section of the roundtable discussion, participants describe how their individual managed care plans approach hypertension from the standpoints of disease management targeting, strategies to combat noncompliance, and how these plans utilize pharmacoeconomic information in drug formulary decision making.
authors.forename: P
authors.initials: P
authors.lastname: Penna
authors.forename: E
authors.initials: E
authors.lastname: Cox
authors.forename: T
authors.initials: T
authors.lastname: Joseph
authors.forename: L
authors.initials: L
authors.lastname: Lehman
authors.forename: T
authors.initials: T
authors.lastname: Morrow
authors.forename: A
authors.initials: A
authors.lastname: Richter
authors.forename: J
authors.initials: J
authors.lastname: Sowers
authors.forename: D
authors.initials: D
authors.lastname: Tepper
mesh_terms: D000959:Antihypertensive Agents / Q000191:economics / Q000627:therapeutic use*; D019468:Disease Management; D005569:Formularies as Topic; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008329:Managed Care Programs / Q000191:economics / Q000458:organization & administration*; D010349:Patient Compliance; D014481:United States
chemical_list: D000959:Antihypertensive Agents